Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

NeuroOne Medical Tech Q2 EPS $(0.07) Up From $(0.11) YoY, Sales $1.39M Beat $1.27M Estimate

Author: Benzinga Newsdesk | May 13, 2025 07:31am
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.07) per share. This is a 36.36 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $1.39 million which beat the analyst consensus estimate of $1.27 million by 9.18 percent. This is a 0.69 percent increase over sales of $1.38 million the same period last year.

Posted In: NMTC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist